Skip Navigation LinksSkip Navigation Links
Centers for Disease Control and Prevention
Safer Healthier People
Blue White
Blue White
bottom curve
CDC Home Search Health Topics A-Z spacer spacer
spacer
Blue curve MMWR spacer
spacer
spacer

The content, links, and pdfs are no longer maintained and might be outdated.

  • The content on this page is being archived for historic and reference purposes only.
  • For current, updated information see the MMWR website.

Use of Northern Hemisphere Influenza Vaccines by Travelers to the Southern Hemisphere

The influenza season in temperate climates extends from October through March in the northern hemisphere and from April through September in the southern hemisphere (1--3). Recent studies indicate that influenza viruses can circulate throughout the year in the tropics and that influenza is the most frequently acquired vaccine-preventable disease among those traveling to tropical and subtropical countries (2--5). Influenza outbreaks have been reported among persons who travel from the northern hemisphere to the southern hemisphere and among persons from the northern hemisphere on group tours (4--7). To reduce the risk for influenza during travel, the Advisory Committee on Immunization Practices (ACIP) recommends that persons from the northern hemisphere who are recommended for annual vaccination or who want to avoid influenza illness but have not yet received the 2008--09 influenza vaccine should consider being vaccinated 1) before travel to the southern hemisphere during influenza season, 2) before travel to the tropics at any time of year, or 3) when traveling as part of a tour group that includes persons from areas where influenza circulates during April--September (e.g., the southern hemisphere) (8). Vaccine formulations for each hemisphere are updated yearly but might differ according to virus surveillance information from each hemisphere.

Vaccines prepared for use in the northern hemisphere typically are administered to U.S. travelers to the southern hemisphere, even when the vaccine formulation is less than optimal, because influenza vaccines prepared for use in the southern hemisphere are not widely available in the United States. However, this year the influenza virus strains represented in the 2008--09 northern hemisphere influenza vaccine currently available in the United States are identical to the strains represented in influenza vaccines intended for use in 2009 in the southern hemisphere (8,9).

Health-care providers should ask patients about upcoming travel plans, inform them regarding the risk for influenza during travel, and be aware that vaccination of travelers with the currently available northern hemisphere influenza vaccine will provide the most recently updated vaccine formulation for the southern hemisphere.

The expiration dates in the prescribing information indicate that certain lots of northern hemisphere influenza vaccines in the United States can be used as late as June 30, 2009. If possible, influenza vaccine should be administered to travelers a minimum of 2 weeks before departure, but can be administered up to the date of travel. No information is available regarding the benefits of revaccinating persons before summer travel who already were vaccinated during the preceding fall (8). In addition, before their trip, persons should learn about health risks in the destination country (information available at http://www.cdc.gov/travel). Members of the public, especially those at higher risk for influenza complications, should consult with their health-care practitioner to discuss the risk for influenza and other travel-related diseases before embarking on travel (4,8).

References

  1. Strikas RA, Kozarsky PE, Reed C, Kapella BK, Freedman DO. Should health-care providers in the United States have access to influenza vaccines formulated for the southern hemisphere? J Travel Med 2008;15:442--6.
  2. Camps M, Vilella A, Marcos MA, et al. Incidence of respiratory viruses among travelers with a febrile syndrome returning from tropical and subtropical areas. J Med Virol 2008;80:711--5.
  3. Chew FT, Doraisingham S, Ling AE, Kumarasinghe G, Lee BW. Seasonal trends of viral respiratory tract infections in the tropics. Epidemiol Infect 1998;121:121--8.
  4. CDC. Health information for international travel 2008. Atlanta: US Department of Health and Human Services, CDC; 2008. Available at http://wwwn.cdc.gov/travel/contentyellowbook.aspx.
  5. Marti F, Steffen R, Mutsch M. Influenza vaccine: a travelers' vaccine? Expert Rev Vaccines 2008;7:679--87.
  6. Brotherton JM, Delpech VC, Gilbert GL, et al. A large outbreak of influenza A and B on a cruise ship causing widespread morbidity. Epidemiol Infect 2003;130:263--71.
  7. Uyeki TM, Zane SB, Bodnar UR, et al. Large summertime influenza A outbreak among tourists in Alaska and the Yukon Territory. Clin Infect Dis 2003;36:1095--102.
  8. CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR 2008;57(No. RR-7).
  9. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2009 southern hemisphere influenza season. Wkly Epidemiol Rec 2008;83:366--72.

Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.


References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

Date last reviewed: 4/2/2009

HOME  |  ABOUT MMWR  |  MMWR SEARCH  |  DOWNLOADS  |  RSSCONTACT
POLICY  |  DISCLAIMER  |  ACCESSIBILITY

Safer, Healthier People

Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention
1600 Clifton Rd, MailStop E-90, Atlanta, GA 30333, U.S.A

USA.GovDHHS

Department of Health
and Human Services